Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (FLGT) Revenue
Annual & quarterly revenue history · segment & region breakdown
FLGT · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsFulgent Genetics, Inc. trailing twelve-month (TTM) revenue is $0.32B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Medical - Diagnostics & ResearchCompare FLGT revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Fulgent Genetics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Fulgent Genetics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Fulgent Genetics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
FLGT revenue · 4 questionsFLGT's trailing twelve-month (TTM) revenue is $0.32B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Fulgent Genetics, Inc. SEC filings · GAAP · Fulgent Genetics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026